Subhasmita Bhal
Bhubaneshwar, OR, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
5-FU in combination with PARP inhibitor ABT-888 deregulates MGMT-dependent mismatch repair (MMR) pathway in MMR-proficient colorectal cancer stem cells by modulating MGMT/PARP1/MSH6 complex.
Journal: Expert opinion on therapeutic targets
Published: July 17, 2026
Talazoparib enhances the anti-angiogenic potential of quinacrine through the deregulation of P300 and GCN5 chromatin remodelers in patient-derived oral cancer stem cells.
Journal: 3 Biotech
Published: September 03, 2025
Harnessing the immune system: Insights into cancer vaccines.
Journal: Advances in immunology
Published: July 30, 2025
Resveratrol nanoparticles inhibit epithelial-to-mesenchymal transition in oral cancer via p53-independent p21-mediated downregulation of survivin.
Journal: International journal of biological macromolecules
Published: May 31, 2025
Amphiphilic Poly(ethylene glycol)-Cholesterol Conjugate: Stable Micellar Formulation for Efficient Loading and Effective Intracellular Delivery of Curcumin.
Journal: ACS applied bio materials
Published: February 05, 2025
Resveratrol nanoparticles induce apoptosis in oral cancer stem cells by disrupting the interaction between β-catenin and GLI-1 through p53-independent activation of p21.
Journal: Medical oncology (Northwood, London, England)
Published: March 30, 2024
In silico-guided discovery and in vitro validation of novel sugar-tethered lysinated carbon nanotubes for targeted drug delivery of doxorubicin.
Journal: Journal of molecular modeling
Published: February 20, 2024
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation.
Journal: Medical oncology (Northwood, London, England)
Published: October 16, 2023
Talazoparib enhances the quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300.
Journal: Medical oncology (Northwood, London, England)
Published: September 15, 2023
Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 01, 2023
Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics.
Journal: Medical oncology (Northwood, London, England)
Published: September 16, 2022
Quinacrine and Curcumin in combination decreased the breast cancer angiogenesis by modulating ABCG2 via VEGF A.
Journal: Journal of cell communication and signaling
Published: June 20, 2022
Last Updated: 09/26/2026